Molecules/TISLELIZUMAB

TISLELIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2023

Mechanism of action: Programmed cell death protein 1 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BGB-A317BGBA-317BGBA317BGN-1BGN1JHL-2108JHL2108TEVIMBRATISLELIZUMABTISLELIZUMAB-JSGRTIZVENI

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to TISLELIZUMAB

Loading drug network...